Jonathan Barnett on Competition Regulators and Standard-Essential Patents – Center for the …
The following post comes from Connor Sherman, a 2L at Scalia Law and a Research Assistant at CPIP. By Connor Sherman The field of intellectual …
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
US vs China: Goodwin Attorneys Discuss Patent Hurdles and Adalimumab Marketing
Huiya Wu, JD, and Freddy Yip, PhD, PCLL, attorneys at Goodwin Procter, discussed biologic drug patent laws in China and the US.
-
In: PATENT NEWS
Reminder to all Canadian Patent Applicants: Late National Phase Entry as of Right Soon Coming …
By Patricia Folkins and Dominique Lambert Following ratification of the Patent Law Treaty (PLT) by Canada, new Patent.
-
In: PATENT NEWS
Abacus Health Solutions Secures Patent on Behavioral Science approach to Chronic Health Condition Management – PRNewswire
Abacus Health Solutions Secures Patent on Behavioral Science approach to Chronic Health Condition Management PRNewswire
-
In: PATENT NEWS
Novartis Patent on Entresto Survives Patent Office Challenge Bid – Bloomberg Law
Novartis Patent on Entresto Survives Patent Office Challenge Bid Bloomberg Law
-
In: PATENT NEWS
Ohio University announces patent and technology license agreement with American Resources Corporation – Ohio University
Ohio University announces patent and technology license agreement with American Resources Corporation Ohio University
-
In: PATENT NEWS
Samsung wins a Design Patent for a Foldable Tablet Display that Industry Players like Dell, HP and others may use in new 2021-2022 Devices – Patently Apple
Samsung wins a Design Patent for a Foldable Tablet Display that Industry Players like Dell, HP and others may use in new 2021-2022 Devices Patently Apple
-
In: PATENT NEWS
Novartis Patent on Entresto Survives Patent Office Challenge Bid
Novartis Patent on Entresto Survives Patent Office Challenge Bid · More from Bloomberg Law.
-
In: PATENT NEWS
Adamis Pharmaceuticals Strengthens Patent Portfolio for Its Naloxone Product Candidate – BioSpace
Adamis Pharmaceuticals Strengthens Patent Portfolio for Its Naloxone Product Candidate BioSpace
-
In: PATENT NEWS
Novartis Asks SCOTUS to Deny Review of Gilenya Patent Decision
Novartis Asks SCOTUS to Deny Review of Gilenya Patent Decision · More from Bloomberg Law.